Essilor launches the Stellest™ lens and forges new partnerships to combat the spread of myopia worldwide
In 2020, Essilor introduced the Stellest™ lens in China, a new generation of spectacle lens solutions that slow the progression of myopia in children.
The first-year results of an ongoing clinical trial using the Stellest™ lens show more than 60% slowdown in myopia progression on average, when compared to children wearing single vision lenses.
As part of our ongoing efforts to combat this visual impairment, Essilor has also promoted white papers published by the International Myopia Institute (IMI). In October, Essilor announced a partnership with Myopia Profile, a global information platform, to develop educational content designed to help eye care professionals. The goal is to enhance their knowledge and skills for managing myopia in children more effectively.